0001493152-21-017380.txt : 20210721 0001493152-21-017380.hdr.sgml : 20210721 20210721082015 ACCESSION NUMBER: 0001493152-21-017380 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210721 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 211102815 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 8-K 1 form8-k.htm
0001360214 false 0001360214 2021-07-21 2021-07-21 0001360214 HROW:CommonStock0.001ParValuePerShareMember 2021-07-21 2021-07-21 0001360214 HROW:Sec8.625SeniorNotesDue2026Member 2021-07-21 2021-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 21, 2021

 

HARROW HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-35814   45-0567010

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

102 Woodmont Blvd., Suite 610    
Nashville, Tennessee   37205
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (615) 733-4730

 

  Not Applicable  
  (Former Name or Former Address, if Changed Since Last Report)  

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name on exchange on which registered
Common Stock, $0.001 par value per share   HROW   The NASDAQ Global Market
8.625% Senior Notes due 2026   HROWL   The NASDAQ Global Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Act of 1934: Emerging growth company ☐

 

If any emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 8.01. Other Information

 

On July 21, 2021, Surface Ophthalmics, Inc. (“Surface”) issued a press release (the “Surface PR”) announcing that it had secured gross proceeds of approximately twenty-five million dollars ($25,000,000) in a private placement of its preferred stock at a purchase price of $4.50 per share. According to the Surface PR, the proceeds from this round of financing is expected to be used to complete ongoing Phase II clinical studies of SURF-100 and SURF-200, and expand the Surface leadership team.

 

Harrow Health, Inc. owns three million five hundred thousand (3,500,000) shares of Surface common stock, along with a mid-single digit royalty right on net sales of SURF-100, SURF-200 and SURF 201.

 

The foregoing is only a brief description of the Surface PR, does not purport to be a complete description of the Surface PR and is qualified in its entirety by reference to the full text of the document, which is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

All trademarks referenced in this Current Report on Form 8-K and the Surface PR are the property of their respective owners.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

Item   Description
     
99.1   Surface Ophthalmics Press Release Date July 21, 2021

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HARROW HEALTH, INC.
   
Dated: July 21, 2021 By: /s/ Andrew R. Boll
  Name: Andrew R. Boll
  Title: Chief Financial Officer

 

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

Surface Ophthalmics Announces $25 Million Private Round of Fundraising

 

Proceeds from the capital raise will help to support and advance Surface’s ongoing clinical programs in ocular diseases

 

PLEASANTON, California, 21 July 2021 – Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced it has secured gross proceeds of approximately $25 million in a private placement of preferred stock, at a purchase price of $4.50 per share. Investors in this round of financing included both new and existing investors made up of institutional, healthcare-focused, and other accredited investors, including members of the Surface Board of Directors.

 

The proceeds from this round of capital raising will be used to complete the ongoing Phase II clinical trial of SURF-100, an innovative head-to-head study comparing SURF-100 against leading on-market competitors lifitegrast ophthalmic solution 5% and cyclosporine ophthalmic emulsion 0.05% along with the Phase II clinical trial of SURF-200, being studied as a potential treatment for acute dry eye disease. Both studies are expected to deliver readouts in the first quarter of 2022. Additionally, Surface is preparing a head-to-head Phase III program for its SURF-201 drug candidate against difluprednate ophthalmic emulsion 0.05% following previously announced outstanding Phase II results. Surface also intends to expand its leadership team and operations to support ongoing ocular surface disease clinical programs that are expected to start in 2022.

 

Following the completion of current Phase II studies, the company will be positioned to begin enrolling patients in Phase III clinical trials, targeting FDA approval, for all three of its ophthalmic product candidates: SURF-100, SURF-200 and SURF-201.

 

“We’re excited by this new capital which will allow us to continue our development programs for truly innovative therapies in the eye care space utilizing our three core building blocks, Klarity®, betamethasone and mycophenolate sodium, to support a healthy ocular surface and a positive experience for dry eye and post-ocular surgery patients,” said Kamran Hosseini, MD, PhD, President and CEO, Surface Ophthalmics. “We believe that this strong fundraising round demonstrates the confidence and excitement, from both our existing investor base and new investors, in our model and clinical programs.”

 

Newbridge Securities Corporation is acting as the exclusive placement agent for the financing. Black River Wealth Management at Newbridge was primarily responsible for sourcing and executing the financing.

 

ABOUT OUR CLINICAL PROGRAMS

 

Surface Ophthalmics is advancing three clinical programs: one in chronic dry eye disease (SURF-100), one in acute dry eye (SURF-200), and one in pain and inflammation following ocular surgery (SURF-201). These programs utilize Klarity® as the delivery vehicle, which is designed to enhance patient comfort as well as protect and rehabilitate the ocular surface.

 

In only three years, Surface has filed three unique INDs and officially moved all three of the programs into Phase II trials.

 

ABOUT KLARITY®

 

The patented Klarity® delivery vehicle is used across Surface Ophthalmics’ three current clinical programs. Developed by Richard L. Lindstrom, MD, inventor of Optisol GS (an advanced corneal preservation solution), Klarity is designed to enhance patient comfort as well as protect and rehabilitate the ocular surface pathology for patients with moderate-to-severe dry eye disease.

 

ABOUT SURFACE OPHTHALMICS

 

Surface Ophthalmics, Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases. We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency, and clear, differentiated clinical advantages. Our current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity®, a patented delivery vehicle. We are led by an experienced and proven management team and board of directors with over 80 years of ophthalmology related professional experience. For more information: http://www.surfaceophthalmics.com.

 

CONTACTS

 

Media Inquiries

Lindsey Reichelt

lindsey@reicheltcommunications.com

 

 

 

 GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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�S7X7/W4E_\ K445;;[G-R0;U2-W2_"VEZ8P>&U+2#I),YD8?GTK M2O(Y)+9EA)W$C(!P2,\C/;BBBH;N=48J*LD)91O$CAP54ME$+;BH^M1V]K*E MY--)*=K,=J ]N.M%%(H+J"YDN0T,FV,!V#_7%0:A!<2[' MMGVM&K'&[ 8D< _YXHHH 6>&5[.) "Q7;YBAL%AW&:EM@R1JK1E !T+[L<], *T44 3T444 ?_V0$! end EX-101.SCH 4 hrow-20210721.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 hrow-20210721_def.xml XBRL DEFINITION FILE EX-101.LAB 6 hrow-20210721_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.001 par value per share 8.625% Senior Notes due 2026 Statement [Table] Affiliate, Collateralized Security [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 7 hrow-20210721_pre.xml XBRL PRESENTATION FILE XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001360214 2021-07-21 2021-07-21 0001360214 HROW:CommonStock0.001ParValuePerShareMember 2021-07-21 2021-07-21 0001360214 HROW:Sec8.625SeniorNotesDue2026Member 2021-07-21 2021-07-21 iso4217:USD shares iso4217:USD shares 0001360214 false 8-K 2021-07-21 HARROW HEALTH, INC. DE 001-35814 45-0567010 102 Woodmont Blvd. Suite 610 Nashville TN 37205 (615) 733-4730 Not Applicable Common Stock, $0.001 par value per share HROW NASDAQ 8.625% Senior Notes due 2026 HROWL NASDAQ false false false false false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Jul. 21, 2021
Affiliate, Collateralized Security [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 21, 2021
Entity File Number 001-35814
Entity Registrant Name HARROW HEALTH, INC.
Entity Central Index Key 0001360214
Entity Tax Identification Number 45-0567010
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 102 Woodmont Blvd.
Entity Address, Address Line Two Suite 610
Entity Address, City or Town Nashville
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37205
City Area Code (615)
Local Phone Number 733-4730
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Information, Former Legal or Registered Name Not Applicable
Common Stock, $0.001 par value per share  
Affiliate, Collateralized Security [Line Items]  
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol HROW
Security Exchange Name NASDAQ
8.625% Senior Notes due 2026  
Affiliate, Collateralized Security [Line Items]  
Title of 12(b) Security 8.625% Senior Notes due 2026
Trading Symbol HROWL
Security Exchange Name NASDAQ
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 3 96 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://harrowinc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex99-1.htm hrow-20210721.xsd hrow-20210721_def.xml hrow-20210721_lab.xml hrow-20210721_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "hrow-20210721_def.xml" ] }, "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "hrow-20210721_lab.xml" ] }, "presentationLink": { "local": [ "hrow-20210721_pre.xml" ] }, "schema": { "local": [ "hrow-20210721.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 2, "memberStandard": 0, "nsprefix": "HROW", "nsuri": "http://harrowinc.com/20210721", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2021-07-21to2021-07-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://harrowinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2021-07-21to2021-07-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "HROW_CommonStock0.001ParValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value per share" } } }, "localname": "CommonStock0.001ParValuePerShareMember", "nsuri": "http://harrowinc.com/20210721", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "HROW_Sec8.625SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "8.625% Senior Notes due 2026" } } }, "localname": "Sec8.625SeniorNotesDue2026Member", "nsuri": "http://harrowinc.com/20210721", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_AffiliateCollateralizedSecurityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Affiliate, Collateralized Security [Line Items]" } } }, "localname": "AffiliateCollateralizedSecurityLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://harrowinc.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 16 0001493152-21-017380-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-017380-xbrl.zip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end